Lilly Broadens Gene Therapy Push With Adverum Acquisition

 
• By Alaric DeArment
  
Lilly is acquiring gene therapy developer Adverum Biotechnologies. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies